The American Academy of Pediatrics (AAP), an organization made up of more than 67,000 pediatricians, pediatric medical sub-specialists, and surgical specialists, has released its influenza vaccine ...

On July 28, 2025, the FDA approved PTC Therapeutics' sepiapterin (Sephience) to treat adult and pediatric patients with phenylketonuria (PKU), including all age groups and the full spectrum of disease ...

The FDA has approved avatrombopag and new sprinkle formulation for children ≥1 year with chronic ITP, offering an oral, food-flexible treatment option.

The study enrolled infants not selected for risk, a population that has been studied few times with regard to emollient intervention.

Study links early childhood eczema timing to risk of allergies like food allergy, asthma, and rhinitis, with five distinct disease phenotypes identified.

J&J is seeking the first approval for the investigational targeted oral peptide to treat patients 12 years or older with moderate to severe plaque psoriasis.

As children head back to school, pediatric pulmonologist Richard Wong, DO, of Phoenix Children’s, warns that asthma management becomes more complex outside the home. With increased exposure to ...

This week, HHS Secretary Robert F. Kennedy Jr signed the ACIP's recommendation to remove the mercury-based preservative from all influenza vaccines.

Solid Biosciences is planning a phase 1b clinical trial of SGT-501 to treat the catecholaminergic polymorphic ventricular tachycardia heart condition. On July 23, 2025, the FDA granted fast track ...

Joshua Fitch is the senior editor for Contemporary Pediatrics. He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown ...

Dr Mahr is director, Pediatric Allergy, Asthma, and Immunology, Gundersen Health System, La Crosse, Wisconsin, and adjunct clinical professor of Pediatrics, University of Wisconsin School of Medicine ...

Craig McDonald, MD, Chair, Department of Physical Medicine & Rehabilitation at UC Davis Health and investigator in the INSPIRE DUCHENNE trial.